IP Library Granted Patent US 12,096,951
Granted Patent B2
US 12,096,951 · App. 16/367,060 · Granted Sep 24, 2024

System and method for treating ischemic stroke

Inventors: David Barry (San Ramon, CA); Arani Bose (New York, NY)
Assignee: Penumbra, Inc.
A61B17/221A61B17/22A61B2017/00526A61B2017/22034A61B2017/22044A61B2017/22067A61B2017/2215A61B2217/005A61M2025/1052Y10T29/49826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,096,951
App. No.
16/367,060
Granted
Sep 24, 2024
Kind
B2
Abstract

A thromboembolic removal system for treating ischemic stroke, including a guide and occlusion catheter, a delivery and aspiration catheter, an aspiration pump, a thromboembolic receiver, and a thromboembolic separator.

Claims (30)

1. A method for removal of an occlusion from a vasculature system, the method comprising:

positioning a catheter such that a distal tip of the catheter is proximate to the occlusion;

deploying a thromboembolic separator from a lumen of the catheter, wherein:

the thromboembolic separator comprises a base end, a central lumen, and a body formed by a plurality of engagement cages;

each engagement cage is defined by rib extensions that are attached to each other by one or more rib extension joiners, distinct from the rib extensions, wherein ends of the one or more rib extensions extend towards each other to form an apex and a respective rib extension joiner physically couples the ends of the rib extensions to form a peak such that a distal end of the respective rib extension joiner extends towards a distal end of the body;

the thromboembolic separator is folded at in a collapsed configuration;

the thromboembolic separator expands into a deployed configuration engaging the occlusion in order to remove the occlusion from a blood vessel of the vasculature system by advancing the separator from the catheter towards the occlusion;

a pair of proximal uprights of the thromboembolic separator are attached at a proximal apex, wherein, when in the deployed configuration, the pair of proximal uprights extend radially out relative to the central lumen towards the distal tip, and wherein the proximal apex is biased towards, and partially defines, the central lumen;

a pair of distal uprights of the thromboembolic separator are attached at a distal apex, wherein, when in the deployed configuration, the pair of distal uprights extend radially out relative to the central lumen towards the distal tip, and wherein the distal apex is biased towards, and partially defines, the central lumen; and

the pair of proximal uprights, the pair of distal uprights, the proximal apex, and the distal apex frame the engagement cages; and

retracting the catheter after the thromboembolic separator has been deployed, the thromboembolic separator, or both from the vasculature system while the occlusion remains at least partially engaged by the thromboembolic separator.

2. The method of claim 1 , further comprising retracting the thromboembolic separator partially or completely into the lumen of the catheter.

3. The method of claim 1 , further comprising inflating a balloon in the blood vessel to reduce or arrest blood flow.

4. The method of claim 1 , wherein positioning the catheter comprises:

forming a percutaneous incision into the vasculature system; and

introducing one or more catheters through the percutaneous incision and into the blood vessel.

5. The method of claim 1 , further comprising:

injecting contrast dye into the vasculature system, wherein the contrast dye is dispersed by blood flow;

visualizing the vasculature system with fluoroscopy, wherein the contrast dye delineates the vasculature system; and

advancing the catheter through the vasculature to reach the blood vessel under fluoroscopy.

6. The method of claim 1 , wherein retracting the catheter, the thromboembolic separator, or both, comprises retracting the thromboembolic separator into the lumen of the catheter and removing the thromboembolic separator from the vasculature system, while the catheter remains in the blood vessel.

7. The method of claim 1 wherein:

deploying the thromboembolic separator comprises expanding the plurality of engagement cages to engage the occlusion in order to remove the occlusion from the blood vessel; and

wherein retracting the catheter, thromboembolic separator, or both, comprises retracting the thromboembolic separator into the lumen of the catheter while the engagement cages engage the occlusion.

8. The method of claim 7 wherein each of the plurality of engagement cages comprises an attached pair of peaks and expanding the engagement cages comprises expanding portions of the engagement cages into contact with surrounding walls of the blood vessel.

9. The method of claim 7 wherein the plurality of engagement cages is capable of partially or fully enveloping the occlusion.

10. The method of claim 1 wherein the thromboembolic separator comprises a plurality of uprights and a multiplicity of apexes extending between said uprights.

11. The method of claim 10 wherein each apex of the multiplicity of apexes are defined by pairs of struts that extend at an angle from their attachment points to the uprights until they meet a strut extending from an opposite direction.

12. The method of claim 11 wherein the thromboembolic separator further comprises a second group of apexes that extend inwardly toward the central longitudinal axis of the separator, and the second group of apexes comprises pairs of opposing apexes that are coupled one to another.

13. The method of claim 12 wherein at least some of the uprights and a first group of apexes are disposed about a central longitudinal axis of the separator, and the uprights are generally parallel over an entire length of the separator.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 14, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: PENUMBRA, INC.
Reel/Frame 066596/0706 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2020
From: BARRY, DAVID; BOSE, ARANI
To: PENUMBRA, INC.
Reel/Frame 054238/0820 →
SECURITY INTEREST Recorded Apr 24, 2020
From: PENUMBRA, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 052488/0785 →
Continuity (3)
Continuation In Part 15488349 · Apr 14, 2017
Division 13253242 · Oct 5, 2011
Related Publication 20190216476A1 · Jul 18, 2019
Cited By (2)
US 12,582,433 US 12,599,397